CAR-T therapy-based innovations in the enhancement of contemporary anti-tumor therapies
Chimeric antigen receptor T (CAR-T) cell therapy has revolutionized the treatment landscape for hematologic malignancies; however, its efficacy in solid tumors remains limited due to antigen heterogeneity, a suppressive tumor microenvironment, and tumor-intrinsic resistance mechanisms. In parallel,...
Saved in:
| Main Authors: | Wan-Ying Zhang, Lang-Yu Yang, Xing-Xing Fan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1622433/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Organ‐on‐chip for advancing CAR therapy
by: Lightson Ngashangva, et al.
Published: (2025-01-01) -
Unlocking Apoptotic Pathways: Overcoming Tumor Resistance in CAR‐T‐Cell Therapy
by: Zhanna Zhang, et al.
Published: (2024-10-01) -
Effectiveness, Limitations, and Future Perspectives of CAR-T Cell Therapy in Solid Tumor Treatment: A Narrative Review
by: Dmytro Kowalczuk, et al.
Published: (2025-05-01) -
In-depth analysis of the safety of CAR-T cell therapy for solid tumors
by: Jiayi Dong, et al.
Published: (2025-02-01) -
CAR-armored-cell therapy in solid tumor treatment
by: Yan Liu, et al.
Published: (2024-11-01)